Effects of Lower Extremity Neural Mobilization on Gait Biomechanics and Spinal Alignment

March 25, 2026 updated by: Ezgi Ünüvar Yüksel, Izmir Democracy University

Acute Effects of Lower Extremity Neural Mobilization on Gait Biomechanics and Spinal Alignment: A Comparison of Neural Slider and Neural Tensioner Techniques

This randomized single-blinded trial aimed to compare the immediate effects of lower extremity neural slider and neural tensioner exercises on gait parameters and spinal alignment in sedentary young adults. Sixty healthy sedentary individuals aged 18-30 years were randomly assigned to receive either a neural slider or neural tensioner intervention. Spatiotemporal gait parameters were assessed using a validated smartphone-based gait analysis application, and spinal alignment angles were measured with a bubble inclinometer before and immediately after a single exercise session. The primary outcome was the acute change in gait-related parameters, and secondary outcomes included changes in spinal alignment and pelvic inclination angles.

Study Overview

Detailed Description

This randomized, single-blinded experimental study was conducted between February and April 2024 to investigate the acute effects of lower extremity neural mobilization techniques on gait biomechanics and spinal alignment in sedentary individuals.

Sixty healthy sedentary participants (30 females, 30 males) aged 18-30 years were enrolled. Participants were randomly allocated to either a neural slider group or a neural tensioner group using a sealed-envelope randomization method. Allocation concealment was ensured by an independent researcher, and all outcome assessments were performed by a blinded physiotherapist.

Each participant underwent baseline (pre-test) assessments followed by a single session of neural mobilization exercise (3 minutes total, 3 sets of 30 repetitions). Post-intervention measurements were performed five minutes after completion of the exercise.

The primary outcome was the immediate change in spatiotemporal gait parameters, including gait speed, cadence, step length, step length asymmetry, base of support, single and double support times, and gait score. Gait was assessed using the OneStep smartphone application, which has demonstrated high validity compared to laboratory-based gait analysis systems.

Secondary outcomes included changes in spinal alignment and pelvic inclination angles, measured using a bubble inclinometer. Cervical lordosis, thoracic kyphosis, lumbar lordosis, total spinal mobility, and pelvic tilt angles were evaluated in a neutral standing position.

No adverse events were reported during or after the interventions.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Konak
      • Izmir, Konak, Turkey (Türkiye), 35290
        • Izmir Democracy University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age between 18 and 30 years
  • Sedentary lifestyle (no regular structured exercise within the past 6 months)
  • No history of lower extremity or spinal surgery
  • No diagnosed neurological disorder
  • No diagnosed musculoskeletal disorder
  • No current lower extremity pain or functional limitation
  • Willingness to participate and provide written informed consent

Exclusion Criteria:

  • History of hamstring injury
  • Current low back, hip, or knee pain
  • Known peripheral nerve injury or neurological condition
  • Any condition limiting safe participation in neural mobilization exercises
  • Inability to complete the intervention protocol
  • Withdrawal from the study before post-intervention assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neural Slider Group
Lower Extremity Neural Slider Exercise
A lower extremity neural slider technique applied in supine position. The movement sequence involved alternating cervical extension with simultaneous knee extension and ankle dorsiflexion, followed by cervical flexion combined with knee flexion and ankle plantarflexion. The intervention was performed for a total of 3 minutes, consisting of 3 sets of 30 repetitions (90 repetitions total). Each repetition included a 1-second hold at end range. The technique was administered by a physiotherapist under standardized conditions.
Experimental: Neural Tensioner Group
Lower Extremity Neural Tensioner Exercise
A lower extremity neural tensioner technique applied in supine position. The movement sequence involved simultaneous cervical flexion with knee extension and ankle dorsiflexion to increase neural tension, followed by return to neutral position with cervical extension and knee flexion. The intervention lasted 3 minutes and consisted of 3 sets of 30 repetitions (90 repetitions total), with a 1-second hold at end range. The technique was administered by a physiotherapist under standardized conditions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait Speed
Time Frame: baseline and 5 minutes after the intervention
Gait speed expressed in meters per second (m/s), calculated as total walking distance divided by time during a 1-minute walk on a straight, level surface. Measurements were obtained using the OneStep smartphone application, with the smartphone securely attached to the lateral aspect of the thigh to capture inertial motion data. Speed was derived from step detection and stride timing algorithms. The outcome represents the change from pre- to post-intervention.
baseline and 5 minutes after the intervention
Gait Cadence
Time Frame: baseline and 5 minutes after the interventio
Cadence expressed in steps per minute (steps/min), calculated as the total number of detected steps divided by walking time. Step events were identified through thigh-mounted inertial sensor data captured by the OneStep application during a 1-minute walking trial. The outcome represents the change from pre- to post-intervention.
baseline and 5 minutes after the interventio
Step Length
Time Frame: baseline and 5 minutes after the intervention
Step length expressed in centimeters (cm), defined as the linear distance between the initial contact of one foot and the subsequent initial contact of the contralateral foot. Step length was estimated using validated gait algorithms based on stride time and thigh kinematics recorded by the OneStep application. The outcome represents the change from baseline to post-intervention.
baseline and 5 minutes after the intervention
Stride Length
Time Frame: baseline and 5 minute after interventions.
Stride length expressed in centimeters (cm), defined as the linear distance between two successive initial contacts of the same foot. Stride length was derived from inertial sensor data captured from the thigh during standardized walking. The outcome represents the change between pre- and post-intervention.
baseline and 5 minute after interventions.
Step Length Asymmetry
Time Frame: baseline and 5 minute later interventions
ep length asymmetry expressed as a percentage (%), calculated as the normalized difference between right and left step lengths during walking. Values were automatically derived from spatiotemporal gait data recorded by the thigh-mounted smartphone. The outcome represents the change from pre- to post-intervention.
baseline and 5 minute later interventions
Step Width
Time Frame: baseline and 5 minutes later interventions
step width expressed in centimeters (cm), defined as the mediolateral distance between the center points of the heels during consecutive foot contacts. This parameter was estimated using validated spatial gait algorithms within the OneStep application. The outcome represents the change from baseline to post-intervention.
baseline and 5 minutes later interventions
Single Support Time
Time Frame: baseline and 5 minutes after interventions
Right single support time expressed as a percentage of the gait cycle (%), defined as the duration during which only the investigated limb is in contact with the ground. Gait cycle phases were automatically detected using thigh-based inertial motion data. The outcome represents the change from pre- to post-intervention.
baseline and 5 minutes after interventions
Double Support Time
Time Frame: baseline and 5 minutes after interventions
Double support time expressed as a percentage of the gait cycle (%), defined as the duration during which both feet are simultaneously in contact with the ground. This parameter was calculated using gait phase detection algorithms from inertial sensor data recorded during walking. The outcome represents the change between pre- and post-intervention assessments.
baseline and 5 minutes after interventions

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pelvic Inclination Angle
Time Frame: baseline and 5 minutes after interventions
Pelvic inclination angle expressed in degrees (°), measured in standing position using a bubble inclinometer placed between the anterior superior iliac spine (ASIS) and posterior superior iliac spine (PSIS). The angle represents the sagittal plane tilt of the pelvis. The outcome represents the change from pre- to post-intervention.
baseline and 5 minutes after interventions
Cervical Lordosis Angle
Time Frame: baseline and 5 minutes later interventions
Cervical lordosis angle expressed in degrees (°), measured in neutral standing posture using a bubble inclinometer positioned between the spinous processes of C1 and C7. The angle represents sagittal curvature of the cervical spine. The outcome represents the change from baseline to post-intervention.
baseline and 5 minutes later interventions
Thoracic Kyphosis Angle
Time Frame: baseline and 5 minutes after interventions
Thoracic kyphosis angle expressed in degrees (°), measured using a bubble inclinometer placed between T1 and T12 spinous processes in standing posture. The outcome represents the change between pre- and post-intervention measurements.
baseline and 5 minutes after interventions
Lumbar Lordosis Angle
Time Frame: baseline and 5 minutes after interventions
Lumbar lordosis angle expressed in degrees (°), measured using a bubble inclinometer placed between L1 and L5 spinous processes in standing posture. The outcome represents the change from pre- to post-intervention.
baseline and 5 minutes after interventions

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2024

Primary Completion (Actual)

April 23, 2024

Study Completion (Actual)

April 25, 2024

Study Registration Dates

First Submitted

March 18, 2026

First Submitted That Met QC Criteria

March 18, 2026

First Posted (Actual)

March 24, 2026

Study Record Updates

Last Update Posted (Actual)

March 31, 2026

Last Update Submitted That Met QC Criteria

March 25, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • neuralmobilization

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healhty

Clinical Trials on Lower Extremity Neural Slider Exercise

Subscribe